References
- Amidi M, Mastrobattista E, Jiskoot W, et al (2010). Chitosan-Based delivery systems for protein therapeutics and antigens. Advanced Drug Delivery Rev, 62, 59-82. https://doi.org/10.1016/j.addr.2009.11.009
- Anonim (2008). Carbodiimides (EDAC) Heterobifunctionnal cross-linkers, http://www.interchim.fr/ft/5/52005A.pdf, Accessed on 21 November 2013.
- Baeuerle P, Gires O (1993). EpCAM (CD326) finding it is role in cancer. Br J Cancer, 96, 417- 23.
- Barbieri L, Batelli MG, Stirpe F (1993). Ribosome-inactivating proteins from plants. Biochim Biophys Acta, 1154, 237-82. https://doi.org/10.1016/0304-4157(93)90002-6
- Bradford MM (1976). Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248-54. https://doi.org/10.1016/0003-2697(76)90527-3
- De Campos AM, Diebold Y, Carvalho ELS, et al (2004). Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res, 21, 803-10. https://doi.org/10.1023/B:PHAM.0000026432.75781.cb
- Frokjaer S, Otzen DE (2005). Protein drug stability: a formulation challenge, Nat Rev Drug Discov, 4, 298-306. https://doi.org/10.1038/nrd1695
- Gan Q, Wang T (2007). Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B: Biointerfaces, 59, 24-34. https://doi.org/10.1016/j.colsurfb.2007.04.009
- Gombotz WR, Wee SF (1998). Protein Release from alginate matrices. Adv Drug Deliver Rev, 31, 267-85. https://doi.org/10.1016/S0169-409X(97)00124-5
- Grenha A, Seijo B, Remunan-Lopez C, et al (2005). Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci, 25, 427-37. https://doi.org/10.1016/j.ejps.2005.04.009
- Gupta RB (2006). Fundamentals of drug nanoparticles in nanoparticle technology for drug delivery, Eds Gupta RB and Kompella UB. Taylor & Francis Group, New York pp 1-9.
- Hamman JH (2010). Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Marine Drugs, 8, 1305-22. https://doi.org/10.3390/md8041305
- Hartig SM, Greene RR, Dikov MM, et al (2007). Multifunctional nanoparticulate polyelectrolyte complexes. Pharm Res, 24, 2353-69. https://doi.org/10.1007/s11095-007-9459-1
- Hashimoto M, Yang Z, Koya Y, et al (2005). Chitosan in nonviral gene therapy, gene design and delivery, Eds Taira K, Kataoka K, and Niidome T. Springer-Verlag, Tokyo, 63-74.
- Hu C, Chiang C, Yeh (2012). Influence of charge on FITCBSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers. Int J Nanomedicine, 7, 4861-72.
- Hussaana A, Chodidjah, Sismindari, et al (2010). Mekanisme in vitro induksi apoptosis dari RIP (Ribosome-Inactivating Protein) daun bunga pukul empat (Mirabilis jalapa L). Jurnal Sains Medika, 2, 23-31.
- Ikawati Z, Sudjadi, Sismindari (2006). Cytotoxicity against tumor cell lines of a Ribosome-lInactivating Protein (RIP)-like protein isolated from Leaves of Mirabilis jalapa L. Malay J Pharm Sci, 4, 31-41.
- Indrayudha P, Wijayanti N, Sismindari (2011). Antiangiogenesis activity of protein fraction containing MJ-C acidic ribosomeinactivating protein of Mirabilis jalapa L. Jurnal Bahan Alam Indonesia, 7, 277-81.
- Kimman M, Norman R, Jan S, et al (2012). The burden of cancer in member countries of the association of Southeast Asian nations (ASEAN). Asian Pac J Cancer Prev, 13, 411-20. https://doi.org/10.7314/APJCP.2012.13.2.411
- Kocbek P, Obermajer N, Cegnar M, et al (2007). Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Controlled Release, 120, 18-26. https://doi.org/10.1016/j.jconrel.2007.03.012
- Ling J, Liu W, Wang TP (2009). Cleavage of supercoiled doublestranded DNA by several ribosome-inactivating proteins in vitro. FEBS Lett, 345, 143-6.
- Lu F, Wu SH, Hung Y, et al (2009). Size effect on cell uptake in well-suspended. Uniform Mesoporous Silica Nanoparticles. Small, 5, 1408-13. https://doi.org/10.1002/smll.200900005
- Mohanraj VJ, Chen Y (2006). Nanoparticles-a review. Tropical J Pharmaceutical Res, 5, 561-73.
- Mosmann T (1983). Rapid colorimetric sssay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
- Nidhin M, Indumathy R, Sreeram KJ, et al (2008). Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull Mater Sci, 31, 93-6. https://doi.org/10.1007/s12034-008-0016-2
- Osta WA, Chen Y, Mikhitarian K, et al (2004). EpCAM is overexpressed in breast cancer and it is a potential target for breast cancer gene therapy. Cancer Res, 64, 5818-24. https://doi.org/10.1158/0008-5472.CAN-04-0754
- Panyam J, Labhasetwar V (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Rev, 55, 329-47. https://doi.org/10.1016/S0169-409X(02)00228-4
- Peer D, Karp JM, Hong S, et al (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnol, 2, 751-60. https://doi.org/10.1038/nnano.2007.387
- Sarmento B, Ribeiro, Veiga F, et al (2007). Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res, 24, 2198-206. https://doi.org/10.1007/s11095-007-9367-4
- Saether HV, Holme HK, Maurstad G, et al (2008). Polyelectrolyte complex formation using alginate and chitosan. Carbohydr Polym, 74, 813-21. https://doi.org/10.1016/j.carbpol.2008.04.048
- Sismindari, Husaana A, Mubarika S (1998). In vitro cleavage of supercoiled DNA by Annona squamosa extract. MFI, 9, 146-52.
- Sismindari, Hartati MS, Adhyatmika, et al (2010). Cytotoxic selectivity of MJC0.3 and MJC0.5, acidic ribosomeinactivating proteins isolated from Mirabilis jalapa L. leaves against various cancer cell lines. J Med Sci, 42, 39-43.
- Sterzynska K, Kempisty B, Zawierucha P, et al (2012). Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines. Folia Histochem Cytobiol, 50, 534-41. https://doi.org/10.5603/FHC.2012.0075
- Stirpe F (2004). Ribosome-inactivating proteins. Toxicon, 44, 371-83. https://doi.org/10.1016/j.toxicon.2004.05.004
- Sudjadi, Witasari LD, Sadarum MT, et al (2007). Efek sitotoksik suatu protein seperti ribosome-inactivating proteins yang bersifat asam dari daun Mirabilis jalapa L. pada sel kanker. MFI, 18, 8-14.
- Sundar S, Kundu J, Kundu SC, et al (2010). Biopolymeric nanoparticles, Sci Technol Adv Mater, 11, 1-13.
- Torchilin VP, Lukyanov AN (2003). Peptide and protein drug delivery to and into tumors: challenges and solutions, Drug Discov Today, 8, 259-66. https://doi.org/10.1016/S1359-6446(03)02623-0
- Vauthier C, Bouchemal K (2009). Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res, 26, 1025-58. https://doi.org/10.1007/s11095-008-9800-3
- Vivanco JM, Querci M, Salazar LF (1999). Antiviral and antiviroid activity of MAP-containing extracts from Mirabilis jalapa L. roots. Plant Dis, 83, 1116-21. https://doi.org/10.1094/PDIS.1999.83.12.1116
- Zhang H, Wu S, Tao Y, et al (2010). Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system. J Nanomaterials, 2010, 1-5.
Cited by
- A new age for biomedical applications of Ribosome Inactivating Proteins (RIPs): from bioconjugate to nanoconstructs vol.23, pp.1, 2016, https://doi.org/10.1186/s12929-016-0272-1
- Secondary metabolites of Mirabilis jalapa structurally inhibit Lactate Dehydrogenase A in silico: a potential cancer treatment vol.333, pp.1757-899X, 2018, https://doi.org/10.1088/1757-899X/333/1/012078